Reuters logo
BRIEF-Lundbeck study shows Brintellix improves cognitive function
June 16, 2014 / 10:46 AM / 3 years ago

BRIEF-Lundbeck study shows Brintellix improves cognitive function

COPENHAGEN, June 16 (Reuters) - Denmark’s H Lundbeck A/S said: * New results from the CONNECT study shows that Brintellix (vortioxetine) improves cognitive performance and function in adult patients with major depression * Brintellix 10-20 mg/day met the primary study endpoint in adult patients with major depression and showed a statistically significant improvement in cognitive performance as measured by the Digit Symbol Substitution Test versus placebo * The study results are consistent with results from previous studies of Brintellix that demonstrated an improvement in cognitive performance in adult and in elderly patients with major depression * The findings will be presented at the International College of Neuropsychopharmacology World Congress in Vancouver, Canada, on June 24 2014 Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below